BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 18005013)

  • 41. The role of nutrition in hepatic encephalopathy.
    Schulz GJ; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):275-80. PubMed ID: 18403924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Independent prognostic factors in patients with liver cirrhosis.
    Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
    Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough.
    Amodio P; Valenti P; Del Piccolo F; Pellegrini A; Schiff S; Angeli P; Poci C; Mapelli D; Iannizzi P; Gatta A
    Dig Liver Dis; 2005 Nov; 37(11):861-8. PubMed ID: 16183341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 46. [Can FT3 levels facilitate the detection of inflammation or catabolism and malnutrition in dialysis patients?].
    Fernández-Reyes MJ; Sánchez R; Heras M; Tajada P; Iglesias P; García L; García Arévalo MC; Molina A; Rodríguez A; Alvarez-Ude F
    Nefrologia; 2009; 29(4):304-10. PubMed ID: 19668301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of neuropsychological testing and electroencephalogram for early detection of minimal hepatic encephalopathy].
    Choi CS; Kim BI; Lee MH; Choi HS; Kim SH; Ahn DH
    Korean J Hepatol; 2005 Dec; 11(4):329-38. PubMed ID: 16380662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subclinical hepatic encephalopathy: role of tryptophan binding to albumin and the competition with indole-3-acetic acid.
    Greco AV; Mingrone G; Favuzzi A; Bertuzzi A; Gandolfi A; DeSmet R; Vanholder R; Gasbarrini G
    J Investig Med; 2000 Jul; 48(4):274-80. PubMed ID: 10916286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic encephalopathy: suspect it early in patients with cirrhosis.
    Wakim-Fleming J
    Cleve Clin J Med; 2011 Sep; 78(9):597-605. PubMed ID: 21885692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander?
    Yun BC; Kim WR
    Am J Gastroenterol; 2009 Jun; 104(6):1390-1. PubMed ID: 19455127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Secific features of hepatic coma in chronic diseases of the liver in elderly and senile patients].
    Postovit VA; Osipov LN; Zhurkin AT
    Klin Med (Mosk); 1977 Nov; 55(11):81-4. PubMed ID: 606997
    [No Abstract]   [Full Text] [Related]  

  • 53. Diet and cognition in chronic liver disease.
    Kachaamy T; Bajaj JS
    Curr Opin Gastroenterol; 2011 Mar; 27(2):174-9. PubMed ID: 20975555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis.
    Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A
    Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis.
    Ciećko-Michalska I; Senderecka M; Szewczyk J; Panasiuk A; Słowik A; Wyczesany M; Binder M; Mach T
    Adv Med Sci; 2006; 51():273-7. PubMed ID: 17357325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy.
    Amorós A; Aparicio JR; Garmendia M; Casellas JA; Martínez J; Jover R
    Gastrointest Endosc; 2009 Aug; 70(2):262-8. PubMed ID: 19394004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].
    Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R
    Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.